Progenics Pharmaceuticals Announces FDA Approval for AZEDRA® (iobenguane I 131) to Treat Unresect...

The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

ir.progenics.com